2020
DOI: 10.32932/pjnh.2020.01.051
|View full text |Cite
|
Sign up to set email alerts
|

Cryoglobulinemic HCV-related membranoproliferative glomerulonephritis with TMA – secondary HUS or infection-triggered aHUS?

Abstract: Introduction: Membranoproliferative glomerulonephritis is a pattern of glomerular injury on renal biopsy with characteristic light microscopic changes, namely mesangial hypercellularity, endocapillary proliferation and double contour formation along the glomerular capillary walls. This pattern does not represent a disease per se but can occur as a result of different pathologic processes. Case Presentation: We present a case of a 37-year-old caucasian female patient with thrombotic microangiopathy (TMA), sever… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…According to accepted guidelines, aHUS diagnosis is to be considered only after secondary forms of TMA have been excluded 1 . The challenge presented by the well -documented cases reported by Teixeira AC, et al 2 and Diniz H, et al 3 is that even in immune -mediated glomerulonephritis, defects of the alternative pathway complement activation may coexist together with the activation of the classical (by IgG or IgM containing immune complexes) or lectin (by galactose deficient IgA1 containing immune complexes) complement pathways 4 .…”
mentioning
confidence: 99%
“…According to accepted guidelines, aHUS diagnosis is to be considered only after secondary forms of TMA have been excluded 1 . The challenge presented by the well -documented cases reported by Teixeira AC, et al 2 and Diniz H, et al 3 is that even in immune -mediated glomerulonephritis, defects of the alternative pathway complement activation may coexist together with the activation of the classical (by IgG or IgM containing immune complexes) or lectin (by galactose deficient IgA1 containing immune complexes) complement pathways 4 .…”
mentioning
confidence: 99%